← Back to Search
Synthesis And Biological Characterization Of Arylomycin B Antibiotics.
T. Roberts, P. A. Smith, F. Romesberg
Published 2011 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Antibiotics are virtually always isolated as families of related compounds, but the evolutionary forces underlying the observed diversity are generally poorly understood, and it is not even clear whether they are all expected to be biologically active. The arylomycin class of antibiotics is comprised of three related families that are differentiated by nitration, glycosylation, and hydroxylation of a conserved core scaffold. Previously, we reported the total synthesis of an A series member, arylomycin A2, as well as the A series derivative arylomycin C16 and showed that both are active against a broader spectrum of bacteria than previously appreciated. We now report the total synthesis of a B series analogue, arylomycin B-C16, and its aromatic amine derivative. While the aromatic amine loses activity against all bacteria tested, the B series compound shows activities that are similar to the A series compounds, except that it also gains activity against the important pathogen Streptococcus agalactiae.
This paper references
Functions encoded by pyrrolnitrin biosynthetic genes from Pseudomonas fluorescens.
S. Kirner (1998)
Influence of ion pairing, steric effects, and other specific interactions on the reactivity of thioanions with chloronitrobenzenes. Nucleophilic aromatic substitution vs. reduction
S. Montanari (1991)
The gene cluster for chloramphenicol biosynthesis in Streptomyces venezuelae ISP5230 includes novel shikimate pathway homologues and a monomodular non-ribosomal peptide synthetase gene.
J. He (2001)
Why are secondary metabolites (natural products) biosynthesized?
D. Williams (1989)
Expanding the soil antibiotic resistome: exploring environmental diversity.
Vanessa M D'Costa (2007)
Prevention of group B streptococcal disease in the newborn.
B. Apgar (2005)
Coevolution of antibiotic production and counter-resistance in soil bacteria.
Paris Laskaris (2010)
Pathways of Nitrosobenzene Reduction by Thiols in Alcoholic Media.
S. Montanari (1999)
Intramolecular Suzuki-Miyaura reaction for the total synthesis of signal peptidase inhibitors, arylomycins A(2) and B(2).
Jérémy Dufour (2010)
Natural products--a simple model to explain chemical diversity.
R. Firn (2003)
Structural and initial biological analysis of synthetic arylomycin A2.
T. Roberts (2007)
Crystallographic and Biophysical Analysis of a Bacterial Signal Peptidase in Complex with a Lipopeptide-based Inhibitor*
M. Paetzel (2004)
Biosynthesis of Nitro Compounds
Robert Winkler (2007)
The frailty of adaptive hypotheses for the origins of organismal complexity
M. Lynch (2007)
Chemical warfare between microbes promotes biodiversity
T. Czárán (2002)
The Biosynthesis of Nitro Compounds: The Enzymatic Oxidation to Pyrrolnitrin of Its Amino‐Substituted Precursor
S. Kirner (1994)
The role of natural environments in the evolution of resistance traits in pathogenic bacteria
J. Martínez (2009)
The biosynthesis of the pseudomonas antibiotic obafluorin from p-aminophenylalanine and glycine (glyoxylate)
R. Herbert (1990)
One pathway, many products.
M. Fischbach (2007)
From Tars to Products: How To Disentangle the Reactions of Nitrobenzenes with Nucleophiles
C. Paradisi (1999)
Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tü 6075. I. Taxonomy, fermentation, isolation and biological activities.
J. Schimana (2002)
Iodination of Phenols by Use of Benzyltrimethylammonium Dichloroiodate(1
S. Kajigaeshi (1987)
Biosynthetic origin of the rare nitroaryl moiety of the polyketide antibiotic aureothin: involvement of an unprecedented N-oxygenase.
Jing He (2004)
Call of the wild: antibiotic resistance genes in natural environments
H. Allen (2010)
Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tü 6075. II. Structure elucidation.
A. Hoeltzel (2002)
Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I*
P. Kulanthaivel (2004)
Marcel Faber Roundtable: Is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration?
R. Baltz (2005)
The evolution of secondary metabolism – a unifying model
R. Firn (2000)
First and second generation total synthesis of the teicoplanin aglycon.
D. Boger (2001)
In vitro reconstitution and crystal structure of p-aminobenzoate N-oxygenase (AurF) involved in aureothin biosynthesis
Yoo Seong Choi (2008)
Nitroaromatic Compounds, from Synthesis to Biodegradation
Kou-San Ju (2010)
On the evolution of functional secondary metabolites (natural products)
M. J. Stone (1992)
Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.
P. A. Smith (2010)
This paper is referenced by
Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.
C. Walsh (2013)
New antibiotics from Nature's chemical inventory.
Timothy A. Wencewicz (2016)
Streptomyces spp from Black Pepper Rhizosphere: A Boundless Reservoir of Antimicrobial and Growth Promoting Metabolites
T. Anusree (2019)
Synthesis and characterization of the arylomycin lipoglycopeptide antibiotics and the crystallographic analysis of their complex with signal peptidase.
J. Liu (2011)
A Putative Cro-Like Repressor Contributes to Arylomycin Resistance in Staphylococcus aureus
Arryn Craney (2015)
Chapter 7 Bacterial Signal Peptidases
M. Paetzel (2019)
Origins of Yersinia pestis Sensitivity to the Arylomycin Antibiotics and the Inhibition of Type I Signal Peptidase
Danielle B. Steed (2015)
Structural diversity in echinocandin biosynthesis: the impact of oxidation steps and approaches toward an evolutionary explanation
Wolfgang Hüttel (2017)
Polishing the tarnished silver bullet: the quest for new antibiotics
M. Blaskovich (2017)
Nichtproteinogene Aminosäurebausteine für Peptidgerüste aus nichtribosomalen Peptiden und hybriden Polyketiden
C. Walsh (2013)
Type I signal peptidase and protein secretion in Staphylococcus aureus.
Mark A Schallenberger (2012)
Latent antibiotics and the potential of the arylomycins for broad-spectrum antibacterial activity
Yun Xuan Tan (2012)
Signal peptidase I: Cleaving the way to mature proteins
Sarah M. Auclair (2012)
Bacterial Signal Peptidases.
M. Paetzel (2019)
Solid-Phase Synthesis of Biaryl Cyclic Lipopeptides Derived from Arylomycins
Iteng Ng-Choi (2020)
Structure and mechanism of Escherichia coli type I signal peptidase.
M. Paetzel (2014)
Synthesis of Biaryl‐Bridged Cyclic Peptides via Catalytic Oxidative Cross‐Coupling Reactions
Mor Ben-Lulu (2020)
Structural aspects of phenylglycines, their biosynthesis and occurrence in peptide natural products.
Rashed S Al Toma (2015)
Investigating the bioactivity of cells and cell-free extracts of Streptomyces griseus towards Fusarium oxysporum f. sp. cubense race 4
Fathima Ameena Zacky (2013)
SpsB Signal Peptidase
D. Harris (2013)
Synthesis, characterization, and crystal structure of 2-iodo-3,4,5-trimethoxybenzoic acid
Iliyan Kolev (2013)
Mechanism of Action of the Arylomycin Antibiotics and Effects of Signal Peptidase I Inhibition
P. Smith (2012)
Strained cyclophane natural products: macrocyclization at its limits.
Tanja Gulder (2012)